ArticlePharmaceuticals (Basel, Switzerland)2024

Pembrolizumab-Associated Cardiotoxicity: A Retrospective Analysis of the FDA Adverse Events Reporting System.

Stefan Milutinovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.